Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 93.95
+0.75 (0.80%)
Jul 31, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 86.54 billion as of July 31, 2026. Its market cap has decreased by -36.90% in one year.
Market Cap
86.54B
Enterprise Value
81.29B
Revenue
3.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
93.95
ChartMarket Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 86.54B, an increase of 366.68%. That is a compound annual growth rate of 27.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 86.54B | -16.86% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 161.61B |
| Innovent Biologics | 156.16B |
| Sichuan Kelun-Biotech Biopharmaceutical | 118.94B |
| Sino Biopharmaceutical | 93.12B |
| RemeGen | 65.64B |
| Biocytogen Pharmaceuticals (Beijing) | 49.57B |
| 3SBio | 43.56B |
| Genscript Biotech | 36.79B |